Toyin Ajayi, MD, MPhil, is Chief Health Officer at Sidewalk Labs’ Care Lab, a New York–based health and social services company focused on providing integrated health and social care for low-income urban populations with complex health and social needs.
Prior to this, Dr. Ajayi served as Chief Medical Officer at Commonwealth Care Alliance (CCA), a Massachusetts nonprofit health plan and integrated care delivery system created to provide high quality care to people with complex health needs. In this role, she directed clinical programs and oversaw clinical care delivery, care management, and clinical operations.
Dr. Ajayi is a board-certified family physician and maintains an active clinical practice. Prior to joining CCA in 2013, Dr. Ajayi was an attending physician at BMC’s Department of Family Medicine where she was awarded the Department’s Faculty Teaching Award in 2013, and a clinical instructor at Boston University’s School of Public Health.
Prior to joining CCA in 2013, Dr. Ajayi was an attending physician at BMC’s Department of Family Medicine where she was awarded the Department’s Faculty Teaching Award in 2013, and a clinical instructor at Boston University’s School of Public Health.
Dr. Ajayi received her undergraduate degree from Stanford University; an MPhil from the University of Cambridge; and her medical degree, with Distinction in Clinical Practice, from King’s College London School of Medicine.
It’s about having a system and team in place that allows physicians to act on the information patients provide.
Article by Iyah K. Romm, John Loughnane, Matthew Goudreau & Toyin Ajayi
Mobile integrated health, a disruptive home-based delivery model, repurposes existing resources and addresses critical care gaps for high-risk, high-cost populations.
Creating an environment that engenders trust is critical, but is it measurable?
Talk by Toyin Ajayi
How do we align our goals for patient engagement with even the most complex, difficult patients?
Article by Maria C. Raven, Iyah K. Romm & Toyin Ajayi
Policymakers see programs for complex patient populations as a way to bend the health care cost curve, but are reduced health care utilization and costs the right measures of success?